ACRS
Aclaris Therapeutics Inc.
$3.35
+$0.08(+2.29%)
65
Overall
60
Value
91
Tech
44
Quality
Market Cap
$263.28M
Volume
1.49M
52W Range
$1.05 - $4.03
Target Price
$7.67
EPS Estimates Overview
| Current Quarter | $-0.15 | Next Quarter | $-0.14 |
| Current Year | $-0.51 | Next Year | $-0.55 |
| QoQ Growth | +6.7% | YoY Growth | -7.8% |
| 3Y EPS CAGR | -2.2% | Target Price | $7.67 |
| Consensus | Buy | Upside | +129.3% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ACRS | $3.35 | +2.3% | 1.49M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Aclaris Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW